fbpx Skip to main content

BioCommunique Article

Bringing you the latest life science investing news and business headlines.

Revolution Medicines Snags $238M in IPO; Manufacturing of Gilead’s Remdesivir for Coronavirus; Vineti Bags $35M for Logistics Software Build

  • 2020-02-13T22:49:00.000+0000
  • California
  • Author: Lauren Panetta